Chad Messer
Stock Analyst at Lake Street
(1.14)
# 3,795
Out of 4,988 analysts
488
Total ratings
38.2%
Success rate
-0.4%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSTX OS Therapies | Reiterated: Buy | $13 | $1.77 | +634.46% | 20 | Sep 9, 2026 | |
| CGEN Compugen | Reiterated: Buy | $5 → $6 | $2.49 | +140.96% | 4 | Jul 21, 2026 | |
| CNSY Cerenome | Reiterated: Buy | $50 | $2.03 | +2,363.05% | 6 | Jul 1, 2026 | |
| GNLX Genelux | Reiterated: Buy | $16 | $2.53 | +532.41% | 6 | Jun 30, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $103 | $96.47 | +6.77% | 7 | Jun 30, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $10.39 | +207.99% | 1 | Jun 11, 2026 | |
| IMNM Immunome | Reiterated: Buy | $30 | $23.97 | +25.16% | 9 | Jun 1, 2026 | |
| ONCY Oncolytics Biotech | Reiterated: Buy | $5 | $0.77 | +549.35% | 18 | Jun 1, 2026 | |
| COYA Coya Therapeutics | Reiterated: Buy | $17 | $4.89 | +247.65% | 14 | May 22, 2026 | |
| LTRN Lantern Pharma | Reiterated: Buy | $25 | $1.55 | +1,512.90% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $3.56 | +2,006.74% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.83 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $8.03 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.30 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $7.72 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $6.01 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $80.61 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $68.78 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $6.12 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.9157 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.94 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $90.25 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $44.44 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.02 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.0001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $25.44 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $30 | $58.36 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.60 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $20.11 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.303 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.07 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.20 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $27 | $17.85 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $7.98 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.0001 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $11.49 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.06 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.08 | n/a | 1 | May 22, 2012 |
OS Therapies
Sep 9, 2026
Reiterated: Buy
Price Target: $13
Current: $1.77
Upside: +634.46%
Compugen
Jul 21, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $2.49
Upside: +140.96%
Cerenome
Jul 1, 2026
Reiterated: Buy
Price Target: $50
Current: $2.03
Upside: +2,363.05%
Genelux
Jun 30, 2026
Reiterated: Buy
Price Target: $16
Current: $2.53
Upside: +532.41%
Monopar Therapeutics
Jun 30, 2026
Reiterated: Buy
Price Target: $103
Current: $96.47
Upside: +6.77%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $10.39
Upside: +207.99%
Immunome
Jun 1, 2026
Reiterated: Buy
Price Target: $30
Current: $23.97
Upside: +25.16%
Oncolytics Biotech
Jun 1, 2026
Reiterated: Buy
Price Target: $5
Current: $0.77
Upside: +549.35%
Coya Therapeutics
May 22, 2026
Reiterated: Buy
Price Target: $17
Current: $4.89
Upside: +247.65%
Lantern Pharma
May 18, 2026
Reiterated: Buy
Price Target: $25
Current: $1.55
Upside: +1,512.90%
May 13, 2026
Reiterated: Buy
Price Target: $75
Current: $3.56
Upside: +2,006.74%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.83
Upside: -
Nov 1, 2021
Reiterated: Buy
Price Target: $6 → $7
Current: $8.03
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $1.30
Upside: n/a
Aug 13, 2021
Reiterated: Buy
Price Target: $29
Current: $7.72
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $49
Current: $6.01
Upside: n/a
Aug 10, 2021
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $80.61
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $68.78
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $6.12
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $0.9157
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $1.94
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $90.25
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $44.44
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $40.02
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $25.44
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $33 → $30
Current: $58.36
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.60
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $20.11
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.303
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $33.07
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $4.20
Upside: n/a
Apr 12, 2018
Reiterated: Buy
Price Target: $30 → $27
Current: $17.85
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $7.98
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.0001
Upside: n/a
Mar 6, 2015
Reiterated: Buy
Price Target: $7 → $4
Current: $11.49
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $1.06
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $1.08
Upside: n/a